SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001062993-14-000064
Filing Date
2014-01-08
Accepted
2014-01-08 11:07:56
Documents
7
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A form20fa.htm 20-F/A 757461
2 EXHIBIT 12.1 exhibit12-1.htm EX-12.1 6931
3 EXHIBIT 12.2 exhibit12-2.htm EX-12.2 6945
4 EXHIBIT 13.1 exhibit13-1.htm EX-13.1 2881
5 EXHIBIT 13.2 exhibit13-2.htm EX-13.2 2858
6 GRAPHIC financialsx1x1.jpg GRAPHIC 2658
7 GRAPHIC financialsx2x1.jpg GRAPHIC 1996
  Complete submission text file 0001062993-14-000064.txt   785066
Mailing Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1
Business Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1 416 593-3701
Merus Labs International Inc. (Filer) CIK: 0001031516 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 20-F/A | Act: 34 | File No.: 000-30082 | Film No.: 14515452
SIC: 2834 Pharmaceutical Preparations